Skip to Main Content
Table 2

Hypoglycemic events during intravenous and subcutaneous insulin treatment

Intravenous insulin therapyGlulisineRegular
Patients with BG <70 mg/dl (%) 4 (12) 6 (18) 
Episodes of BG <70 mg/dl 
Patients with BG <40 mg/dl, n (%) 0 (0) 0 (0) 
Episodes of BG <40 mg/dl 
Intravenous insulin therapyGlulisineRegular
Patients with BG <70 mg/dl (%) 4 (12) 6 (18) 
Episodes of BG <70 mg/dl 
Patients with BG <40 mg/dl, n (%) 0 (0) 0 (0) 
Episodes of BG <40 mg/dl 
Subcutaneous insulin therapyGlargine/glulisineNPH/regular
Patients with BG <70 mg/dl (%) 5 (15) 14 (41)* 
Episodes of BG <70 mg/dl 26 
Patients with BG <40 mg/dl, n (%) 1 (3) 2 (6) 
Episodes of BG <40 mg/dl 
Subcutaneous insulin therapyGlargine/glulisineNPH/regular
Patients with BG <70 mg/dl (%) 5 (15) 14 (41)* 
Episodes of BG <70 mg/dl 26 
Patients with BG <40 mg/dl, n (%) 1 (3) 2 (6) 
Episodes of BG <40 mg/dl 

Data are n or n (%).

*P = 0.03;

P = 0.019. BG, blood glucose.

Close Modal

or Create an Account

Close Modal
Close Modal